Brind.

Entities / Person

Feng Ren.

researcher (ORCID 0000-0001-9157-9182)

Seen in 3 reportsLast reported Oct 30

Reports this week: 0
Active events: 0
Connections: 1

What's happening

Gone quiet

No new reports in 90+ days

Insilico Medicine is conducting a Phase I study in Australia, and Feng Ren serves as Co-CEO and Chief Scientific Officer.

Some support2 reports

Around Feng Ren this week

News at the entities that move Feng Ren most

Insilico Medicine Structural
Insilico Medicine developed PLSI for the Grok Bot platform in collaboration with David Sinclair, a researcher from Harvard Medical School.

Moves Feng Ren
Fri 16:58

Connections

Strongest first. The bars show how strongly a change on one side reaches the other.

Insilico Medicine Structural

Feng Ren holds the critical leadership roles of Co-CEO and Chief Scientific Officer at Insilico Medicine.

Some supportOct 30

Feng Ren → Insilico Medicine
Insilico Medicine → Feng Ren

History

Events by the month they began

June 2026

1 event

Jun 17, 2026Insilico Medicine is conducting a Phase I study in Australia, and Feng Ren serves as Co-CEO and Chief Scientific Officer.